2024 ICD-10-CM Diagnosis Code D65

Disseminated intravascular coagulation [defibrination syndrome]

ICD-10-CM Code:
D65
ICD-10 Code for:
Disseminated intravascular coagulation
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Not chronic
Code Navigator:

Code Classification

  • Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
    (D50–D89)
    • Coagulation defects, purpura and other hemorrhagic conditions
      (D65-D69)
      • Disseminated intravascular coagulation [defibrination syndrome]
        (D65)

D65 is a billable diagnosis code used to specify a medical diagnosis of disseminated intravascular coagulation [defibrination syndrome]. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Abnormal fibrinolysis
  • Abnormal fibrinolysis
  • Acquired afibrinogenemia
  • Acquired fibrinogen abnormality
  • Acquired purpura fulminans
  • Afibrinogenemia
  • Consumption coagulopathy caused by snake venom
  • Disseminated intravascular coagulation
  • Drug-induced fibrinolytic disorder
  • Drug-induced fibrinolytic disorder
  • Fibrinolytic bleeding syndrome
  • Fibrinolytic disorder caused by tissue plasminogen activator
  • Fibrinolytic disorder caused by urokinase
  • Hyperfibrinolysis
  • Increased fibrinolysis
  • Purpura fulminans
  • Secondary non-thrombocytopenic purpura
  • Secondary non-thrombocytopenic purpura
  • Systemic fibrinogenolysis

Clinical Classification

Clinical Information

  • Disseminated Intravascular Coagulation

    a disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. the activation of the clotting mechanism may arise from any of a number of disorders. a majority of the patients manifest skin lesions, sometimes leading to purpura fulminans.
  • Purpura Fulminans

    a severe, rapidly fatal reaction occurring most commonly in children following an infectious illness. it is characterized by large, rapidly spreading skin hemorrhages, fever, or shock. purpura fulminans often accompanies or is triggered by disseminated intravascular coagulation.
  • Waterhouse-Friderichsen Syndrome

    a condition of hemorrhage and necrosis of the adrenal gland. it is characterized by rapidly developing adrenal insufficiency; hypotension; and widespread cutaneous purpura.
  • Afibrinogenemia

    a deficiency or absence of fibrinogen in the blood.
  • Fibrinogen

    plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides a and b, the proteolytic action of other enzymes yields different fibrinogen degradation products.
  • Afibrinogenemia

    a blood coagulation disorder characterized by the complete absence of fibrinogen in the blood, resulting in bleeding.

Tabular List of Diseases and Injuries

The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.


Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Afibrinogenemia, acquired
  • Consumption coagulopathy
  • COVID-19 associated diffuse or disseminated intravascular coagulopathy
  • Diffuse or disseminated intravascular coagulation DIC
  • Fibrinolytic hemorrhage, acquired
  • Fibrinolytic purpura
  • Purpura fulminans

Code Also

Code Also
A "code also" note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction.
  • , if applicable, associated condition

Type 1 Excludes

Type 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • disseminated intravascular coagulation (complicating):
  • abortion or ectopic or molar pregnancy O00 O07 O08.1
  • in newborn P60
  • pregnancy, childbirth and the puerperium O45.0 O46.0 O67.0 O72.3

Index to Diseases and Injuries References

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

Convert D65 to ICD-9-CM

  • ICD-9-CM Code: 286.6 - Defibrination syndrome

Patient Education


Bleeding Disorders

Normally, if you get hurt, your body forms a blood clot to stop the bleeding. For blood to clot, your body needs cells called platelets and proteins known as clotting factors. If you have a bleeding disorder, you either do not have enough platelets or clotting factors or they don't work the way they should.

Bleeding disorders can be the result of other diseases, such as severe liver disease or a lack of vitamin K. They can also be inherited. Hemophilia is an inherited bleeding disorder. Bleeding disorders can also be a side effect of medicines such as blood thinners.

Various blood tests can check for a bleeding disorder. You will also have a physical exam and history. Treatments depend on the cause. They may include medicines and transfusions of blood, platelets, or clotting factor.


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.